← Back to Patent Explorer
US4613576A Expired / Lapsed US ⏱️ 0.0 years remaining

Human monoclonal antibodies to cancer cells

Assignee: Memorial Sloan Kettering Cancer Center
•
Filing: 1983-03-09
•
Granted: 1986-09-23
•
Expires: 2003-03-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hybridomas which produce human monoclonal antibodies are disclosed. The hybridomas are formed by fusing lymphocytes from individuals with various cancers to an immortal cell line, such as a myeloma, from, e.g., a human cell line, or a mouse cell line.

Inventors

  • 👤 Richard J. Cote
  • 👤 Donna M. Morrissey
  • 👤 Alan N. Houghton
  • 👤 Edward J. Beattie, Jr.
  • 👤 Herbert F. Oettgen
  • 👤 Lloyd J. Old

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 19:33
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/30; C07K16/3023; C07K16/3015; C07K16/3038; C07K16/3061

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 23 words
Human monoclonal antibody producing hybridoma cell line where the product of said cell line specifically binds to cell surface antigen system HB 8223.
Claim 2
Dependent Claim 23 words
Human monoclonal antibody producing hybridoma cell line where the product of said cell line specifically binds to cell surface antigen system HB 8223.
Claim 3
Dependent Claim 26 words
Human monoclonal antibody producing hybridoma cell lines where the product of said cell lines specifically bind to intracellular antigens HB 8237, HB 8238 or HB 8239.
Claim 4
Dependent Claim 26 words
Human monoclonal antibody producing hybridoma cell lines where the product of said cell lines specifically bind to intracellular antigens HB 8237, HB 8238 or HB 8239.
Claim 5
Dependent Claim 22 words
Human monoclonal antibodies which specifically bind to cell surface antigen HB 8223 or intracellular antigens HB 8237, HB 8238, or HB 8239.
Claim 6
Dependent Claim 22 words
Human monoclonal antibodies which specifically bind to cell surface antigen HB 8223 or intracellular antigens HB 8237, HB 8238, or HB 8239.
Claim 7
Dependent Claim 64 words
An immunoassay for human cells comprising contracting said cells with at least one monoclonal antibody selected from the group consisting of HB 8223, HB 8237, HB 8238, HB 8239 under conditions favoring formation of an antigen:antibody complex between said antibody and an antigen or antigens to which said antibodies specifically bind, and observing the formation of said complex or the absence of said formation.
Claim 8
Dependent Claim 64 words
An immunoassay for human cells comprising contracting said cells with at least one monoclonal antibody selected from the group consisting of HB 8223, HB 8237, HB 8238, HB 8239 under conditions favoring formation of an antigen:antibody complex between said antibody and an antigen or antigens to which said antibodies specifically bind, and observing the formation of said complex or the absence of said formation.
Claim 9
Dependent Claim 10 words
Immunoassay of claim 4 with human monoclonal antibody HB 8223.
Claim 10
Dependent Claim 10 words
Immunoassay of claim 4 with human monoclonal antibody HB 8237.
Claim 11
Dependent Claim 10 words
Immunoassay of claim 4 with human monoclonal antibody HB 8238.
Claim 12
Dependent Claim 10 words
Immunoassay of claim 4 with human monoclonal antibody HB 8239.
Claim 13
Dependent Claim 15 words
Method of diagnosis of tumors comprising immunoassay of claim 4 of an excised human specimen.
Claim 14
Dependent Claim 31 words
Method of detecting cytoplasmic cytoskeletal perinuclear and nuclear components of human cells comprising immunoasay of claim 4 of said cells with human monoclonal antibody HB 8237, HB 8238, or HB 8239.
Claim 15
Dependent Claim 16 words
Panel of phenotyping human monoclonal antibodies comprising HB 8223, HB 8237, HB 8238, and HB 8239.
Claim 16
Dependent Claim 16 words
Panel of phenotyping human monoclonal antibodies comprising HB 8223, HB 8237, HB 8238, and HB 8239.

References Cited (Backward Citations)

EP0044722A1 Cited
WO1982001461A1 Cited
US4434230A Cited
EP0073953A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-09-22 1990-03-24 1990-09-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-09-22 1994-03-24 1994-09-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-09-22 1998-03-24 1998-09-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag